Research programme: atopic dermatitis/psoriasis therapeutic - Bioiberica

Drug Profile

Research programme: atopic dermatitis/psoriasis therapeutic - Bioiberica

Alternative Names: Aquasorb

Latest Information Update: 28 Jul 2016

Price : $50

At a glance

  • Originator Bioiberica
  • Class Glycosaminoglycans; Lipids
  • Mechanism of Action
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase Unknown Atopic dermatitis; Psoriasis

Most Recent Events

  • 28 Jul 2016 Investigation in Psoriasis in Spain (Topical)
  • 28 Jul 2016 Investigation in Atopic dermatitis in Spain (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top